Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 64.81%-3.27M | ---- | 47.11%-9.3M | ---- | -61.24%-17.58M | ---- | 11.59%-10.9M | ---- | 35.57%-12.33M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 51.85%-13K | ---- | -285.71%-27K | ---- | 50.00%-7K | ---- | -27.27%-14K | ---- | -57.14%-11K |
| Impairment and provisions: | ---- | -120.34%-1.13M | ---- | 26.79%5.57M | ---- | 524.01%4.39M | ---- | 618.37%704K | ---- | -75.00%98K |
| -Impairment of trade receivables (reversal) | ---- | -145.16%-1.69M | ---- | -14.74%3.73M | ---- | 503.59%4.38M | ---- | 639.80%725K | ---- | -78.37%98K |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | --17K | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | -69.98%552K | ---- | --1.84M | ---- | ---- | ---- | ---21K | ---- | ---- |
| Revaluation surplus: | ---- | -89.76%344K | ---- | 50.00%3.36M | ---- | -41.05%2.24M | ---- | 733.33%3.8M | ---- | -398.51%-600K |
| -Fair value of investment properties (increase) | ---- | -89.76%344K | ---- | 50.00%3.36M | ---- | -41.05%2.24M | ---- | 733.33%3.8M | ---- | ---600K |
| Asset sale loss (gain): | ---- | 99.34%-1K | ---- | -410.20%-152K | ---- | 100.59%49K | ---- | ---8.3M | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | 99.39%-51K | ---- | ---8.3M | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 99.34%-1K | ---- | -252.00%-152K | ---- | --100K | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | -2.43%4.05M | ---- | -4.64%4.15M | ---- | 38.75%4.35M | ---- | -13.98%3.14M | ---- | 30.33%3.65M |
| Financial expense | ---- | 105.63%329K | ---- | -74.03%160K | ---- | -11.11%616K | ---- | 45.59%693K | ---- | -14.39%476K |
| Special items | ---- | ---- | ---- | -102.49%-10K | ---- | -39.37%402K | ---- | 111.15%663K | ---- | -12.78%314K |
| Operating profit before the change of operating capital | ---- | -91.88%305K | ---- | 167.91%3.76M | ---- | 45.85%-5.53M | ---- | -21.52%-10.22M | ---- | 43.35%-8.41M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | 94.05%-629K | ---- | 33.12%-10.57M | ---- | -10,298.71%-15.81M | ---- | 109.89%155K | ---- | 76.53%-1.57M |
| Accounts payable increase (decrease) | ---- | -108.92%-711K | ---- | -10.23%7.97M | ---- | 3,813.81%8.88M | ---- | -102.86%-239K | ---- | -12.63%8.36M |
| prepayments (increase)decrease | ---- | 216.43%674K | ---- | -90.08%213K | ---- | 306.63%2.15M | ---- | 3.94%528K | ---- | -56.06%508K |
| Financial assets at fair value (increase)decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1,482.81%1.01M |
| Special items for working capital changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 126.82%603K |
| Cash from business operations | ---- | -126.47%-361K | ---- | 113.22%1.36M | ---- | -5.58%-10.32M | ---- | -2,031.03%-9.77M | ---- | 103.90%506K |
| Other taxs | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 17.22%-226K |
| Special items of business | 103.58%152K | -10,011.11%-1.78M | -389.75%-4.25M | -99.03%18K | 80.23%-868K | 710.48%1.86M | 31.81%-4.39M | --229K | -333.89%-6.44M | ---- |
| Net cash from operations | 103.58%152K | -255.21%-2.15M | -389.75%-4.25M | 116.34%1.38M | 80.23%-868K | 11.34%-8.46M | 31.81%-4.39M | -3,507.86%-9.54M | -333.89%-6.44M | 102.11%280K |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -51.85%13K | ---- | 285.71%27K | ---- | -50.00%7K | ---- | 27.27%14K | ---- | 57.14%11K |
| Sale of fixed assets | ---- | -99.07%2K | ---- | 5,300.00%216K | ---- | --4K | ---- | ---- | ---- | ---- |
| Purchase of fixed assets | ---- | 72.54%-39K | ---- | -52.69%-142K | ---- | 82.01%-93K | ---- | 4.26%-517K | ---- | -1,185.71%-540K |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | -100.45%-53K | ---- | --11.7M | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | --90K | ---- | ---- | ---- | ---- |
| Other items in the investment business | -85.71%3K | ---- | -85.31%21K | ---- | 497.22%143K | ---- | 87.92%-36K | ---- | -159.13%-298K | ---- |
| Net cash from investment operations | -85.71%3K | -123.76%-24K | -85.31%21K | 324.44%101K | 497.22%143K | -100.40%-45K | 87.92%-36K | 2,216.45%11.2M | -159.13%-298K | -368.14%-529K |
| Net cash before financing | 103.66%155K | -246.26%-2.17M | -483.45%-4.23M | 117.44%1.48M | 83.62%-725K | -614.21%-8.51M | 34.29%-4.43M | 764.26%1.65M | -355.38%-6.74M | 98.14%-249K |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | 332.89%11.08M | --11.08M | -85.02%2.56M | ---- | -6.38%17.09M | ---- | 10.92%18.26M | ---- | 9.74%16.46M |
| Refund | ---- | 87.96%-3.79M | 118.41%4.72M | -136.23%-31.51M | ---25.64M | 22.21%-13.34M | ---- | -301.83%-17.15M | 24.70%-753K | 56.61%-4.27M |
| Issuing shares | ---- | ---- | ---- | --32.18M | --32.19M | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | ---- | -105.63%-329K | ---- | 74.03%-160K | ---- | 11.11%-616K | ---- | -45.59%-693K | ---- | 14.39%-476K |
| Adjustment item of financing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --30K | ---- |
| Net cash from financing operations | -117.36%-2.46M | 491.14%3.13M | 217.11%14.16M | -20.45%-801K | 304.21%4.46M | 59.62%-665K | 13.39%-2.19M | -115.98%-1.65M | -415.50%-2.52M | 157.79%10.3M |
| Effect of rate | 231.76%224K | -106.54%-316K | 23.42%-170K | 60.97%-153K | -12.12%-222K | 18.67%-392K | 37.14%-198K | -65.07%-482K | 59.09%-315K | -105.94%-292K |
| Net Cash | -123.19%-2.3M | 41.35%964K | 165.47%9.93M | 107.44%682K | 156.54%3.74M | -131,100.00%-9.17M | 28.59%-6.61M | -99.93%7K | -369.37%-9.26M | 207.33%10.06M |
| Begining period cash | 7.58%9.2M | 6.59%8.55M | 6.59%8.55M | -54.38%8.02M | -54.38%8.02M | -2.63%17.58M | -2.63%17.58M | 117.68%18.06M | 117.68%18.06M | -34.93%8.3M |
| Cash at the end | -61.10%7.12M | 7.58%9.2M | 58.65%18.31M | 6.59%8.55M | 7.11%11.54M | -54.38%8.02M | 27.00%10.77M | -2.63%17.58M | -22.63%8.48M | 117.68%18.06M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Rongcheng (Hong Kong) Certified Public Accountants Limited | -- | KPMG (Hong Kong) Limited | -- | KPMG (Hong Kong) Limited | -- | KPMG (Hong Kong) Limited | -- | National Health Accounting Firm Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.